Loading people...
Dave Barrett is a Managing Partner at Polaris Partners in Boston, Massachusetts, where he co-leads the technology investment practice and manages multiple vehicles including the $400 million Polaris Fund X. Before joining the firm in 2000, he served as Chief Operating Officer of Calico, scaling the company to a $3.5 billion market value, and held executive roles at Pure Atria and Lotus Development prior to their respective $2 billion and $3.5 billion acquisitions by IBM. As an investor focused on enterprise software, artificial intelligence, and healthcare technology, he has backed numerous successful companies, securing board seats at Automattic, Egnyte, and Cohere Health. A former Forbes Midas List recipient, he also serves on the board of the Dana-Farber Cancer Institute. Barrett leverages his operational background to guide early and growth-stage startups transforming digital health and cloud infrastructure.
As a Managing Partner at Polaris Partners, Dave Barrett stands at the forefront of venture capital, driving innovation primarily within the life sciences and healthcare sectors. His leadership at Polaris Partners is instrumental in identifying, funding, and developing companies poised to make significant impacts in biotechnology, medical devices, and healthcare information technology. Barrett's investment philosophy is characterized by a hands-on approach, often working closely with entrepreneurs from inception to market leadership.
Barrett's extensive career background is deeply rooted in the healthcare industry, providing him with a profound understanding of its complexities and opportunities. Before his tenure as Managing Partner, he honed his expertise through various roles that equipped him with a unique perspective on company formation, strategic development, and operational excellence. This rich experience allows him to not only spot promising technologies but also to actively contribute to their growth, guiding them through critical stages of development and commercialization.
His portfolio reflects a commitment to pioneering solutions that address unmet medical needs. Dave Barrett has been a key figure in the success stories of numerous companies that have gone on to transform patient care. While specific investments are often a collaborative effort at Polaris, his influence is evident in companies that have achieved significant milestones in drug discovery, advanced diagnostics, and innovative medical therapies. He has been particularly involved with companies like Akebia Therapeutics, which focuses on kidney disease, and Arsenal Medical, a developer of novel biomaterial based medical devices. His work with firms such as Ironwood Pharmaceuticals and Receptos further underscores his dedication to fostering breakthroughs in pharmaceutical development and immunology.
Through his strategic vision and deep industry connections, Dave Barrett continues to shape the future of healthcare. His dedication to fostering entrepreneurial talent and his unwavering focus on impactful innovation make him a pivotal figure in the venture capital landscape, consistently seeking out the next generation of healthcare leaders and technologies.
Dave Barrett is a Managing Partner at Polaris Partners, a leading venture capital firm. He is a prominent investor specializing in life sciences and healthcare, known for his active role in building innovative companies.
Dave Barrett primarily invests in the life sciences and healthcare sectors. His focus areas include biotechnology, medical devices, and healthcare information technology, seeking companies with groundbreaking solutions.
Dave Barrett works as a Managing Partner at Polaris Partners, a distinguished venture capital firm. Polaris Partners has offices in Boston and San Francisco, among other locations.
